Clinical Trial Update: Comparison of Repaglinide and Metformin Combination Tablet Versus Repaglinide and Metformin as Separate Tablets in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial update comparing a repaglinide/metformin combination tablet with separate repaglinide and metformin tablets in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Prandin (repaglinide)
• metformin (metformin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED